Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL

Clinical trial NCT03406000 · COMPLETED

Trial details

NCT number: NCT03406000
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type I Diabetes Mellitus

Start date: 2018-01-22
Primary completion: 2019-02-04
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.